Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

ISASS 2021 – The International Society for the Advancement of Spine Surgery

2021-05-13 – 2021-05-15 / English / Congress…

Superbug MRSA arose in hedgehogs long before clinical use of antibiotics.

Superbug MRSA arose in hedgehogs long before…

Treating COVID-19: Are we overusing antimicrobials?

Medical News Today recently reported on a study…

TRATAMIENTO PARA LA ARTROSIS – SYNOLIS VA

ALTA CONCENTRACIÓN DE ANTIOXIDANTES  …

DÍA DEL MÉDICO EN MÉXICO – 23 DE OCTUBRE

Aunque a nivel mundial el día del médico se…

El estilo de vida bacteriano altera la evolución de la resistencia a los antibióticos.

Investigadores de la Facultad de Medicina de la…

Gene-editing produces tenfold increase in superbug slaying antibiotics

ScienceDaily recently featured a study conducted…

ChatGPT Health: la nueva apuesta de OpenAI para consultas de salud

¿Una consulta médica con ChatGPT? La empresa…

6 de enero Día de la Enfermera

Felicidades a todas las enfermeras y enfermeros…